Skip to main content
SpringerLink
Log in

Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Plasma concentrations and urinary excretion of DTZ and its metabolites were determined in 20 healthy volunteers (10 males and 10 females) after they had each been given a single oral 90 mg dose of DTZ. DTZ and six of its metabolites which included N-monodesmethyl DTZ (MA), deacetyl DTZ (M1), deacetyl N-monodesmethyl DTZ (M2), deacetyl O-desmethyl DTZ (M4) and deacetyl DTZ N-oxide (M1NO) and deacetyl N,O-didesmethyl DTZ (M6), were determined by a sensitive and specific HPLC assay. The major metabolites measurable in the plasma of all the volunteers were MA, M1, and M2. The terminal half-lives (t1/2) of M1 and M2 were considerably longer than those of DTZ and MA. Less than 5% of the dose was excreted as unchanged DTZ in the urine over the 24 h period. The major urinary metabolite was MA, followed by M6, M2, and then M1. Except for the urinary excretion of M4 there were no statistically significant differences in any of the pharmacokinetic parameters between the males and the females. The mean 24 h urinary recovery of M4 was higher in the males than in the females (P< 0.05). However there were large inter-individual variations in the plasma concentrations and urinary excretion of DTZ and its metabolites with some parameters differing by more than 20-fold. In addition, O-desmethyl DTZ (Mx) and N,O-didesmethyl DTZ (MB) were identified as two other major urinary metabolites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bourassa M.G. (1985): Haemodynamic and electrophysiologic effects of diltiazem. Acta Pharmacol. Toxicol., 57, Suppl. II, 21–30.

    Google Scholar 

  2. Kendall M.J. Okopski J.V. (1986): Calcium antagonism-with special reference to diltiazem. J. Clin. Hosp. Pharm., 11, 159–174.

    CAS  PubMed  Google Scholar 

  3. Halperin A.K., Cubeddu L.X., Albuquerque N.M. (1986): The role of calcium channel blockers in the treatment of hypertension. Am. Heart J., 111 (2), 363–382.

    Article  CAS  PubMed  Google Scholar 

  4. Meshi T., Sugihara J., Sato Y. (1971): Metabolic fate of d-cis-3-acetoxy-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride (CRD-401). Chem. Pharm. Bull., 19, 1546–1556.

    CAS  PubMed  Google Scholar 

  5. Sugihara J., Sugawara Y., Ando H., Harigaya S., Etoh A., Kohno K. (1984): Studies on the metabolism of diltiazem in man. J. Pharmacobiodyn., 7, 24–32.

    CAS  PubMed  Google Scholar 

  6. Yabana H., Nagao T., Sato M. (1985): Cardiovascular effects of the metabolites of diltiazem in dogs. J. Cardiovasc. Pharmacol., 7, 152–157.

    Article  CAS  PubMed  Google Scholar 

  7. Schoemaker H., Hicks P.E., Langer S.Z. (1987): Calcium channel receptor binding studies for diltiazem and its major metabolites: Functional correlation to inhibition of portal vein myogenic activity. J. Cardiovasc. Pharmacol., 9, 173–180.

    Article  CAS  PubMed  Google Scholar 

  8. Sugawara, Y., Ohashi M., Nakamura S., et al. (1988): Metabolism of diltiazem. I. Structures of new acidic and basic metabolites in rats, dog and man. J. Pharmacobiodyn., 11, 211–223.

    CAS  PubMed  Google Scholar 

  9. Kiyomoto A., Sasaki Y., Odawara A., Morita T. (1983): Inhibition of platelet aggregation by diltiazem. Circ. Res., 52 (Suppl. 1), 115–119.

    CAS  Google Scholar 

  10. Yeung P.K.F., Mosher S.J., MacRae D.A., Klassen G.A. (1991): Effect of diltiazem and its metabolites on the uptake of adenosine in blood: An in-vitro investigation. J. Pharm. Pharmacol., 43, 685–689.

    CAS  PubMed  Google Scholar 

  11. Kinney E.L., Moskowitz R.M., Zelis R. (1981): The pharmacokinetics and pharmacology of oral diltiazem in normal volunteers. J. Clin. Pharmacol., 21, 337–342.

    CAS  PubMed  Google Scholar 

  12. Hermann P., Morselli P.L. (1985): Pharmacokinetics of diltiazem and other calcium entry blockers. Acta Pharmacol. Toxicol., 57 (Suppl. II), 10–20.

    CAS  Google Scholar 

  13. Montamat S.C., Abemethy D.R. (1987): N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives. Br. J. Clin. Pharmacol., 24, 185–189.

    CAS  PubMed  Google Scholar 

  14. Hung J., Hackett P.L., Gordon S.P.F., Ilett K.F. (1988): Pharmacokinetics of diltiazem in patients with unstable angina pectoris. Clin. Pharmacol. Ther., 43, 466–470.

    CAS  PubMed  Google Scholar 

  15. Hoglund P., Nilsson L.G. (1989): Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers. Ther. Drug Monit., 11, 558–566.

    Article  CAS  PubMed  Google Scholar 

  16. Smith M.S., Verghese C.P., Shand D.G., Pritchett E.L.C. (1983): Pharmacokinetic and pharmacodynamic effects of diltiazem. Am. J. Cardiol., 51, 1369–1374.

    Article  CAS  PubMed  Google Scholar 

  17. Boyd R.A., Chin S.K., Don-Pedro O., et al. (1989): The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose. Clin. Pharmacol. Ther., 46, 408–419.

    CAS  PubMed  Google Scholar 

  18. Klassen G.A., Yeung P.K.F., Hung O.R., Pollak P.T., Barclay K.D., Mosher S.J. (1993): Should gender differences guide therapeutics. Presented at the 42nd Annual Meeting of the American Colleges of Cardiology, March 1993, Anaheim, California, USA.

  19. Yeung P.K.F., Montague T.J., Tsui B., McGregor C. (1989): High performance liquid chromatographic assay of diltiazem and six of its metabolites in plasma: Application to a pharmacokinetic study in healthy volunteers. J. Pharm. Sci., 78 (7), 592–597.

    Article  CAS  PubMed  Google Scholar 

  20. Li R., Farmer P.S., Xie M., et al. (1992): Synthesis, characterization and calcium antagonistic activity of diltiazem metabolites. J. Med. Chem., 35, 3246–3253.

    Article  CAS  PubMed  Google Scholar 

  21. Caille G., Boucher S., Spenard J., et al. (1991): Diltiazem pharmacokinetics in elderly volunteers after single and multiple doses. Eur. J. Drug Metab. Pharmacokinet., 16 (1), 75–80.

    Article  CAS  Google Scholar 

  22. Goebel K.J., Kolle E.U. (1985): High performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: Application to pharmacokinetics. J. Chromatogr., 345, 355–363.

    Article  CAS  PubMed  Google Scholar 

  23. Hoglund P., Nilsson L.-G. (1987): Liquid chromatographic determination of diltiazem and its metabolites using trans isolid phase by addition of an amine to the mobile phase. J. Chromatogr., 414, 109–120.

    Article  CAS  PubMed  Google Scholar 

  24. Yeung P.K.F., Mosher S.J., Klassen G.A., McGilveray I.J. (1991): Stability of diltiazem and its metabolites in plasma during storage. Ther. Drug Monit., 13, 369–374.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. T. J. Montague (Director)

    Present address: Division of Cardiology, University of Alberta Hospitals, Edmonton, Alberta, Canada

Authors and Affiliations

  1. College of Pharmacy, Faculty of Health Professions, Dalhousie University, B3H 3J5, Halifax, Nova Scotia, Canada

    P. K. F. Yeung, C. McGregor, M. Xei, R. Li & P. Farmer

  2. Division of Cardiology, Victoria General Hospital, Halifax, Nova Scotia, Canada

    C. Prescott, C. Haddad, T. J. Montague (Director) & G. A. Klassen

  3. Institute of Marine Biosciences, National Research Council of Canada, Halifax, Nova Scotia, Canada

    M. A. Quilliam

Authors
  1. P. K. F. Yeung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Prescott
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Haddad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. J. Montague
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. McGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. A. Quilliam
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Xei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Farmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. G. A. Klassen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yeung, P.K.F., Prescott, C., Haddad, C. et al. Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose. Eur. J. Drug Metab. Pharmacokinet. 18, 199–206 (1993). https://doi.org/10.1007/BF03188796

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03188796

Keywords

Search

Navigation